
New Therapeutic Strategies in Lung Cancers
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that have been raised by the discovery of oncogenic drivers and the improvement of diagnosis and therapeutic methods, including new radiotherapy techniques and anticancer strategies like immunotherapy. New strategies for patients with molecular alterations and the management of particular types of cases are also highlighted.Written by recognized experts in their field, the book represents a unique and valuable resource in the field of lung cancer, both for those currently in training and for those already in clinical or research practice. von Peters, Solange und Besse, Benjami
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Solange Peters, MD-PhD, PD-MER, is in charge of the thoracic malignancies program in the Department of Oncology of the University of Lausanne and active in building a translational program in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan as well as the Ludwig Institute. Her main field of interest is new biomarker discovery and validation in preclinical and clinical settings. She is also heavily involved and interested in developing multimodality trials for locally advanced NSCLC. She is co-chair of the Swiss lung cancer research group (SAKK) and Scientific Coordinator as well as Chair of the Informatics Committee of the European Thoracic Oncology Platform (ETOP). She has been elected the Swiss national representative of ESMO in 2013. Dr Benjamin Besse is a cancer specialist, Head of the Thoracic Oncology Unit at the Institut Gustave Roussy in France. His main research interests are application of molecular abnormalities to personalize treatment, phase I trials in thoracic tumors and thymic tumors. He has been the main Investigator of more than 30 phase I and phase II trials in the past 5 years. He coordinates the French network for thymic malignancies. He is associate editor of European Respiratory Journal. He was the coordinating author for the ESMO Guidelines Working Group on Non-Small Cell Lung Cancer (NSCLC) and is Chair of the systemic treatment part of the 2013 ESMO Consensus Conference on Lung Cancer. He is member of the administrative board of the French Intergroup for Thoracic Oncology (IFCT) and Member of ASCO, ESMO and IASLC.
- hardcover
- 1822 Seiten
- Erschienen 2011
- Wiley-VCH
- paperback
- 615 Seiten
- Erschienen 2013
- Humana
- paperback
- 384 Seiten
- Erschienen 2019
- Kensington
- Gebunden
- 426 Seiten
- Erschienen 2013
- Springer
- Kartoniert
- 748 Seiten
- Erschienen 2011
- Humana
- Hardcover
- 164 Seiten
- Erschienen 2022
- Springer International Publ...
- Gebunden
- 331 Seiten
- Erschienen 2009
- Springer-Verlag GmbH
- hardcover
- 585 Seiten
- Erschienen 2013
- Springer
- hardcover
- 311 Seiten
- Erschienen 2003
- Springer
- Gebunden
- 146 Seiten
- Erschienen 2009
- S. Karger
- Kartoniert
- 288 Seiten
- Erschienen 2004
- Elsevier GmbH
- Gebunden
- 546 Seiten
- Erschienen 2011
- Springer
- Kartoniert
- 238 Seiten
- Erschienen 2019
- Springer
- Hardcover
- 692 Seiten
- Erschienen 2008
- MCGRAW HILL EDUCATION & MEDIC
- Gebunden
- 184 Seiten
- Erschienen 2014
- Springer
- Hardcover
- 259 Seiten
- Erschienen 1998
- Klett-Cotta /J. G. Cotta'sc...